Summary
This rat study tested continuous 3,4-diaminopyridine infusion as a symptomatic treatment for lethal botulinum neurotoxin exposure. The drug rapidly reversed respiratory paralysis and improved survival even when treatment began too late for antitoxin, while combined therapy outperformed either treatment alone; hypothermia also preceded visible illness and resolved after treatment. UID UCT-2112 temperature microchips and a URH-1HP reader captured this early biomarker.
Summary written by UID from the published work. Read the original publication for the authors' abstract and full methods.